Decipher Labs Limited reported a net loss of ₹24.68 crore for the financial year ended March 31, 2026, narrowing from a net loss of ₹44.02 crore in the previous year. Revenue from operations for FY26 stood at ₹113.54 crore, an increase from ₹85.32 crore in FY25. The board of directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026.

The statutory auditors, M/s. Ramanathan & Rao, issued an audit report with an unmodified opinion on the standalone and consolidated financial results. The company’s operations span two segments: Manufacturing and Trading of Pharmaceutical drugs and Consultancy Services. For the quarter ended March 31, 2026, the company reported a net loss of ₹17.31 crore, with revenue from operations at ₹6.69 crore.

Standalone Financial Performance

The standalone financial results for FY26 reflect a reduction in net loss despite higher expenses. Total income for the year rose to ₹113.67 crore from ₹87.60 crore in the previous year. Employee benefits expense decreased to ₹17.53 crore from ₹23.43 crore, while other expenses increased to ₹54.08 crore from ₹39.14 crore.

Consolidated Results

On a consolidated basis, the company reported a net loss of ₹308.43 crore for FY26, compared to a net loss of ₹508.02 crore in the previous year. Total revenue from operations for the year was ₹1,405.40 crore. The results include the financial performance of subsidiaries Decipher Software Solutions LLC, USA, and Decipher Soft Middle East W.L.L Bahrain.

The meeting was held pursuant to Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dalavath Amarsingh, Whole Time Director, filed the outcome of the board meeting with the exchange.

Decipher Labs Limited has submitted its quarterly compliance certificate to BSE Limited under SEBI regulations for the quarter ended March 31, 2026. The filing demonstrates the company's adherence to regulatory requirements for securities dematerialization reporting.

Regulatory Compliance Filing

The compliance certificate was filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018. Whole-time Director Dalavath Amarsingh digitally signed the document on April 17, 2026, confirming that all required details have been furnished to stock exchanges where the company's shares are listed.

RTA Confirmation

Venture Capital and Corporate Investments Private Limited, serving as the company's registrar and transfer agent, provided confirmation on April 6, 2026. The RTA certified that no securities were received for dematerialization or rematerialization during the quarter ended March 31, 2026.

Company Information

Decipher Labs Limited operates from its registered office located at A2, Q2, 5th floor, Cyber Towers, Hitech City, Madhapur, Hyderabad – 500081. The company maintains its listing compliance through regular filings with BSE Limited and other applicable stock exchanges.

The quarterly compliance certificate ensures transparency in securities handling and maintains investor confidence through proper regulatory adherence. This filing represents part of the company's ongoing commitment to meet SEBI's regulatory framework for listed entities.